Clinical Nutrition Market (By Route of Administration: Oral, Enteral, and Parental; By Application: Cancer, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others; By End User: Pediatric, Adult, and Geriatric) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024– 2033

The global clinical nutrition market size was exhibited at USD 39.0 billion in 2023 and is projected to hit around USD 72.59 billion by 2033, growing at a CAGR of 6.41% during the forecast period of 2024 to 2033.

Clinical Nutrition Market Size 2024 To 2033

Key Takeaways:

  • The North America segment dominated the global clinical nutrition market in 2023.
  • The route of administration, oral, dominates the clinical nutrition market during the forecast period.
  • The metabolic disorders dominate the clinical nutrition market during the forecast period.
  • The pediatric dominates the clinical nutrition market during the forecast period. 

Clinical Nutrition Market Report Scope

 Report Coverage  Details
Market Size in 2024 USD 39.0 Billion
Market Size by 2033 USD 72.59 Billion
Growth Rate From 2024 to 2033 CAGR of 6.41%
Base Year 2023
Forecast Period 2024-2033
Segments Covered Route of Administration, End User, Application, Region
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional Scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Abbott Laboratories, B. Braun Melsungen AG., Mead Johnson Nutrition Company, Perrigo Company Plc., H.J. Heinz Company, Hospira Inc., Groupe Danone, Fresenius Kabi AG, Baxter International Inc., Nestle SA

 

Growth Factors

The nutrition of patients in the healthcare industry is referred to as clinical nutrition. The goal of clinical nutrition is to help patients maintain a good energy balance while also giving essential nutrients such as minerals, vitamins, and protein. Clinical nutrition has several advantages, including its effectiveness in treating diabetes and its ability to help people live better at any age. Clinical nutrition products are given to people who are unable to absorb or chew food products.

The rise in the incidence of chronic diseases, the number of patients using sophisticated clinical nutritional products, and the growing concern about malnutrition in pediatric patients is all driving the clinical nutrition market growth. The market for clinical nutrition is expected to grow as the elderly population grows and the number of patients suffering from malnutrition grows. Additionally, changing consumer preferences in food consumption, as well as rising demand for nutritional products, are likely to boost the growth of the clinical nutrition market during the forecast period.

The growing consumer awareness of the importance of nutrition for health is driving the global clinical nutrition market. Clinical nutrition sales are being driven by expanding product lines, a constant newborn birth rate, an ageing population, and a variety of other variables around the world. The growing awareness of the connection between health and nutrition, as well as enhancing market conditions, has fueled the expansion of the clinical nutrition market. Furthermore, revenues are expected to be driven by new advances in follow up formulae, product improvements, and other organic formulas over the projection period.

However, obstacles such as government regulatory frameworks, a lack of standard global reimbursement policies combined with economic uncertainty, and the prevalence of patient compliance challenges are projected to stifle global clinical nutrition market expansion. The increasing government measures to improve the current healthcare system, on the other hand, could open up new chances for the clinical nutrition market in the coming years.

One of the primary reasons likely to have a major impact on the overall growth of the global clinical nutrition market is changing consumer patterns in terms of diet and consumption of various nutritional products. With increased internet penetration and availability to digital media, consumer awareness of the benefits of clinical nutrition is on the rise, which is expected to boost the global clinical nutrition market during the forecast period.

While consumer awareness continues to rise, market players are expected to adhere to a strict regulatory framework and focus on product development strategies in order to gain permission from the relevant regulatory body. Several competitors in the current clinical nutrition market are considering extending their product portfolios and production capabilities in order to meet the rising demand for clinical nutrition, especially in the developed regions.

Segments Insights:

Route of Administration Insights

Based on the route of administration, the oral dominates the clinical nutrition market during the forecast period. The increased focus on maintaining a robust immune system has resulted in an increase in demand for oral clinical supplements. The use of oral nutrition in combating malnutrition will contribute to the oral clinical nutrition segment growth.

On the other hand, the parental is expected to grow at rapid pace during the forecast period. The rising frequency of malnutrition among children, particularly in emerging and underdeveloped nations around the world, is one of the primary factors expected to boost demand for parental nutrition.

Application Insights

Based on the application, the metabolic disorders dominate the clinical nutrition market during the forecast period. The demand for clinical nutrition is increasing as the prevalence of metabolic diseases rises. Obesity, diabetes, malnutrition, and cardiovascular diseases contribute to increased hospitalization.

On the other hand, the cancer is expected to grow at rapid pace during the forecast period. Cancer is becoming more common, and people are becoming more aware of the importance of clinical nutrition in cancer treatment. Cancer is one of the top causes of death around the world

End User Insights

Based on the end user, the pediatric dominates the clinical nutrition market during the forecast period. This is attributed to the global incidence of malnutrition and related issues. Malnutrition is a major cause of high mortality and morbidity, particularly in developing and underdeveloped nations.

On the other hand, the geriatric is expected to grow at rapid pace during the forecast period. The geriatric population faces number of disorders. The geriatric population is above 65 years, who requires good amount of nutrition. This factor is driving the growth of the segment.

Key Companies & Market Share Insights

For expansion and diversification, these significant market players place a premium on strategic activities such as new product launches, collaborations, partnerships, and commercialization. Moreover, these industry leaders are heavily spending in research to enable them to introduce novel products to the market and maximize income and profit. Nestle Health Science signed agreement to buy IM HealthScience in August 2020. As public awareness of clinical nutrition grows, so does demand for adult and pediatric nutrition formulae. As a result, key market players are working to provide nutritional solutions that meet all of the needs of the target population around the world.

Some of the prominent players in the clinical nutrition market include:

  • Abbott Laboratories
  • B. Braun Melsungen AG.
  • Mead Johnson Nutrition Company
  • Perrigo Company Plc.
  • H.J. Heinz Company
  • Hospira Inc.
  • Groupe Danone
  • Fresenius Kabi AG
  • Baxter International Inc.
  • Nestle SA

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global clinical nutrition market.

By Route of Administration

  • Oral
  • Enteral
  • Parental

By Application

  • Cancer
  • Metabolic Disorders
  • Gastrointestinal Disorders
  • Neurological Disorders
  • Others

By End User

  • Pediatric
  • Adult
  • Geriatric

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global clinical nutrition market size was exhibited at USD 39.0 billion in 2023 and is projected to hit around USD 72.59 billion by 2033

The global clinical nutrition market is growing at a CAGR of 6.41% from 2023 to 2032.

The major players operating in the clinical nutrition market are Abbott Laboratories, B. Braun Melsungen AG., Mead Johnson Nutrition Company, Perrigo Company Plc., H.J. Heinz Company, Hospira Inc., Groupe Danone, Fresenius Kabi AG, Baxter International Inc., Nestle SA.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Clinical Nutrition Market 

5.1. COVID-19 Landscape: Clinical Nutrition Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Clinical Nutrition Market, By Route of Administration

8.1. Clinical Nutrition Market, by Route of Administration Type, 2024-2033

8.1.1. Oral

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Enteral

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Parental

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Clinical Nutrition Market, By Application

9.1. Clinical Nutrition Market, by Application, 2024-2033

9.1.1. Cancer

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Metabolic Disorders

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Gastrointestinal Disorders

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Neurological Disorders

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Clinical Nutrition Market, By End User 

10.1. Clinical Nutrition Market, by End User, 2024-2033

10.1.1. Pediatric

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Adult

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Geriatric

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Clinical Nutrition Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.1.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Forecast, by End User (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End User (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.2.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Forecast, by End User (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End User (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End User (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End User (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.3.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Forecast, by End User (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End User (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End User (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End User (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End User (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End User (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End User (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Forecast, by End User (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End User (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Route of Administration (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End User (2021-2033)

Chapter 12. Company Profiles

12.1. Abbott Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. B. Braun Melsungen AG.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Mead Johnson Nutrition Company

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Perrigo Company Plc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. H.J. Heinz Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Hospira Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Groupe Danone

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Fresenius Kabi AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Baxter International Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Nestle SA

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers